Roberto Diaz-Beveridge

7PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursRegenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 30, 2026
Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

|Mar 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma.

Javier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge

|Oct 16, 2025
Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines.

Maria Angeles Vaz-Salgado, Claudia Valverde-Morales, Rosa Alvarez

|Jan 08, 2025
Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol.

Juliana Salazar, María J Arranz, Javier Martin-Broto

|Mar 06, 2021
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.

Javier Martínez-Trufero, Luis Miguel De Sande-González, Pablo Luna

|Aug 13, 2017
An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib.

R Diaz-Beveridge, G Bruixola, D Lorente

Pageof 2

Frequent Collaborators

5 joint publications

Javier Martin-Broto

4 joint publications

Javier Martínez-Trufero

3 joint publications

Ana Sebio

3 joint publications

Rosa Alvarez